| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Bendroflumethiazide | Bendroflumethiazide EP Impurity A | VE008427 | View CAS 654-62-6 |
Bendroflumethiazide Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Bendroflumethiazide | Bendroflumethiazide EP Impurity A | VE008427 | View CAS 654-62-6 |
| Catalogue No. | VE008427 |
| CAS No. | 654-62-6 |
| Molecular Formula | C7H8F3N3O4S2 |
| Molecular Weight | 319.28 g/mol |
| Parent drug | Bendroflumethiazide |
| IUPAC Name | 4-Amino-6-(trifluoromethyl)benzene-1, 3-disulfonamide |
| Synonyms | N/A |
| References | Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. By J E Carlsen, L Kober, C Torp-Pedersen, P Johansen Container: BMJ Year: 1990 Volume: 300 Issue: 6730 DOI: 10.1136/bmj.300.6730.975 URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1662719/ |
| Status | In-stock |
| ListName | Bendroflumethiazide EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
